Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2023-10-03 00:00:00 ET · period of report 2023-10-02 · accession 0001662579-23-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-03 | 2023-10-02 | CCCC | GROGAN DONNA ROY | Dir | A - Grant | $1.70 | +8,089 | 19.8K | +69% | +$13.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | A | A | 8,089 | $1.70 | 19,827 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 2, 2023. |